These B-cell stimulatory effects of IL-10 could be important in the perpetuation of RA inflammation because an inflammatory role of B cells in the pathogenesis has recently been supported by clinical efficacy of B-cell depletion therapy with anti-CD20 Ab in patients with RA resistant to TNF-α inhibitors [42]. The gene discussed is TNF; the disease is rheumatoid arthritis.